Literature DB >> 32367404

An exome-first approach to aid in the diagnosis of primary ciliary dyskinesia.

Hanan E Shamseldin1, Ibrahim Al Mogarri2, Mansour M Alqwaiee3, Adel S Alharbi3, Khaled Baqais3, Muslim AlSaadi4, Talal AlAnzi3, Amal Alhashem3,5, Afaf Saghier2, Waleed Ameen6, Niema Ibrahim1, Jason Yang7, Firdous Abdulwahab1, Mais Hashem1, Raghu R Chivukula7, Fowzan S Alkuraya8,9.   

Abstract

Unlike disorders of primary cilium, primary ciliary dyskinesia (PCD) has a much narrower clinical spectrum consistent with the limited tissue distribution of motile cilia. Nonetheless, PCD diagnosis can be challenging due to the overlapping features with other disorders and the requirement for sophisticated tests that are only available in specialized centers. We performed exome sequencing on all patients with a clinical suspicion of PCD but for whom no nasal nitric oxide test or ciliary functional assessment could be ordered. Among 81 patients (56 families), in whom PCD was suspected, 68% had pathogenic or likely pathogenic variants in established PCD-related genes that fully explain the phenotype (20 variants in 11 genes). The major clinical presentations were sinopulmonary infections (SPI) (n = 58), neonatal respiratory distress (NRD) (n = 2), laterality defect (LD) (n = 6), and combined LD/SPI (n = 15). Biallelic likely deleterious variants were also encountered in AKNA and GOLGA3, which we propose as novel candidates in a lung phenotype that overlaps clinically with PCD. We also encountered a PCD phenocopy caused by a pathogenic variant in ITCH, and a pathogenic variant in CEP164 causing Bardet-Biedl syndrome and PCD presentation as a very rare example of the dual presentation of these two disorders of the primary and motile cilia. Exome sequencing is a powerful tool that can help "democratize" the diagnosis of PCD, which is currently limited to highly specialized centers.

Entities:  

Year:  2020        PMID: 32367404     DOI: 10.1007/s00439-020-02170-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  Clinical and molecular characteristics of primary ciliary dyskinesia: A tertiary care centre experience.

Authors:  Mohammed Alzaid; Khalid Al-Mobaireek; Mohammed Almannai; Gawahir Mukhtar; Safa Eltahir; Adnan Zafar; Abdulali P Zada; Wadha Alotaibi
Journal:  Int J Pediatr Adolesc Med       Date:  2021-03-11

2.  The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis.

Authors:  William B Hannah; Bryce A Seifert; Rebecca Truty; Maimoona A Zariwala; Kristen Ameel; Yi Zhao; Keith Nykamp; Benjamin Gaston
Journal:  Lancet Respir Med       Date:  2022-01-17       Impact factor: 102.642

Review 3.  Functional Role of AKNA: A Scoping Review.

Authors:  Abrahán Ramírez-González; Joaquín Manzo-Merino; Carla Olbia Contreras-Ochoa; Margarita Bahena-Román; José Manasés Aguilar-Villaseñor; Alfredo Lagunas-Martínez; Yvonne Rosenstein; Vicente Madrid Marina; Kirvis Torres-Poveda
Journal:  Biomolecules       Date:  2021-11-17

Review 4.  The Role of Centrosome Distal Appendage Proteins (DAPs) in Nephronophthisis and Ciliogenesis.

Authors:  Fatma Mansour; Felix J Boivin; Iman B Shaheed; Markus Schueler; Kai M Schmidt-Ott
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

5.  A Homozygous AKNA Frameshift Variant Is Associated with Microcephaly in a Pakistani Family.

Authors:  Syeda Seema Waseem; Abubakar Moawia; Birgit Budde; Muhammad Tariq; Ayaz Khan; Zafar Ali; Sheraz Khan; Maria Iqbal; Naveed Altaf Malik; Saif Ul Haque; Janine Altmüller; Holger Thiele; Muhammad Sajid Hussain; Sebahattin Cirak; Shahid Mahmood Baig; Peter Nürnberg
Journal:  Genes (Basel)       Date:  2021-09-24       Impact factor: 4.096

6.  Spectrum of Genetic Variants in a Cohort of 37 Laterality Defect Cases.

Authors:  Dinu Antony; Elif Gulec Yilmaz; Alper Gezdirici; Lennart Slagter; Zeineb Bakey; Helen Bornaun; Ibrahim Cansaran Tanidir; Tran Van Dinh; Han G Brunner; Peter Walentek; Sebastian J Arnold; Rolf Backofen; Miriam Schmidts
Journal:  Front Genet       Date:  2022-04-13       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.